Latin America Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnostic Technologies(Molecular Diagnostics, Monoclonal Antibodies, Flow Cytometry, Brain MRI, Spinal Tap, Echocardiogram, Electrocardiogram, Microdroplets)by End Users (hospitals/clinics, Pharmaceutical Industries, Pathology Labs, Research Institutes)and By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Latin America Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnostic Technologies(Molecular Diagnostics, Monoclonal Antibodies, Flow Cytometry, Brain MRI, Spinal Tap, Echocardiogram, Electrocardiogram, Microdroplets)by End Users (hospitals/clinics, Pharmaceutical Industries, Pathology Labs, Research Institutes)and By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 5504 | Pages: 145 | October 2018 | Region: Latin America


Lyme disease is an infectious disease which is caused by bacteria borrelia. It is a tick borne disease caused by the bite of infected ticks. Fever, depression, fatigue and skin rashes are some of the symptoms of lyme disease. It can be treated with antibiotics if it is diagnosed in early stages. But, if the disease is untreated then it affects heart, joint and central nervous system and may cause death

Latin America Lyme Disease Diagnostic Market is worth USD xx million in 2018 and estimated to grow at a CAGR ofxx.xx%, to reach USD xx million by 2023. The Latin America Lyme Disease Diagnostic market is developing at an exceptionally quick pace.

Increasing incidences of Lyme diseaseis expected to be the major growth factor during the forecast period. However inefficiency in lyme disease testing is a major restraint.

Latin America Lyme Disease Diagnostic market is segmented on the basis of Diagnostic Tests, Diagnostic Technologies, End Users and region. Based on Diagnostic Teststhe market is segmented intoDark field microscopy, Urine antigen tests, lymphocytic transformation test, Serological tests, immunofluorescence staining and PCR tests. Based on Diagnostic Technologies the market is segmented intoMolecular diagnostics, Monoclonal antibodies, Flow cytometry, Brain MRI, Spinal tap, Echocardiogram, Electrocardiogram, Microdroplets.Based on End Users the market is segmented intohospitals/clinics, Pharmaceutical Industries, Pathology labs, Research Institutes.

On the basis of geography, the Latin America Lyme Disease Diagnostic industry can be segmented into Brazil,Mexico,Chile, Argentina and others. The rising focus of key players on enhancing their market presence across the globe is estimated to encourage the growth of the market in the Latin America regions.

Boulder Diagnostics, Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd. , Bio-Rad Laboratories,  Alere Inc (ALR), Roche Diagnostics International Ltd., Graphene Frontiers, Covance Inc., Affymetrix Inc.,Siemens AG ,Baxter International Inc., Fresenius Medical Care AG & Co. are the some key players in the Latin America Lyme Disease Diagnosticmarket.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Diagnostic Tests                        

                                5.1.1 Introduction           

                                5.1.2 Serological tests    

                                                5.1.2.1 ELISA (Enzyme-linked Immunosorbent Assay)

                                                5.1.2.2 ELFA (Enzyme-linked Fluorescent Immunoassay)

                                                5.1.2.3 Western Blot

                                5.1.3 Lymphocytic transformation test  

                                5.1.4 Immunofluorescence staining        

                                5.1.5 PCR Analysis           

                                5.1.6 Urine antigen tests              

                                5.1.7 Dark field microscopy         

                                5.1.8  Y-o-Y Growth Analysis, By Diagnostic Tests              

                                5.1.9  Market Attractiveness Analysis, By Diagnostic Tests            

                                5.1.10  Market Share Analysis, By Diagnostic Tests           

                5.2 Diagnostic Technologies                        

                                5.2.1 Introduction           

                                5.2.2 Molecular diagnostics         

                                5.2.3 Brain MRI 

                                5.2.4 Spinal tap 

                                5.2.5 Echocardiogram    

                                5.2.6 Electrocardiogram

                                5.2.7 Monoclonal antibodies      

                                5.2.8 Flow cytometry     

                                5.2.9 Gel micro droplets               

                                5.2.10 Y-o-Y Growth Analysis, By Diagnostic Technologies             

                                5.2.11 Market Attractiveness Analysis, By Diagnostic Technologies           

                                5.2.12 Market Share Analysis, By Diagnostic Technologies            

                5.3 End Users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals / Clinics  

                                5.3.3 Pharmaceutical Industries

                                5.3.4 Pathology labs       

                                5.3.5 Research Institutes             

                                5.3.6 Y-o-Y Growth Analysis, By End Users           

                                5.3.7  Market Attractiveness Analysis, By End Users        

                                5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Tests

                                                6.1.3.3 By Diagnostic Technologies

                                                6.1.3.4 By End Users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Tests

                                                6.1.4.3 By Diagnostic Technologies

                                                6.1.4.4 By End Users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Tests

                                                6.1.5.3 By Diagnostic Technologies

                                                6.1.5.4 By End Users

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Laboratories                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Siemens AG                               

                8.3 GlaxoSmithKline Pharmaceuticals Ltd.                            

                8.4 Fresenius Medical Care AG & Co.                      

                8.5 Baxter International Inc.                       

                8.6 Affymetrix Inc.                          

                8.7 Immunetics Inc.                        

                8.8 Boulder Diagnostics                

                8.9 Roche Diagnostics International Ltd.                

                8.10 Canon U.S. Life Sciences                     

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2018-2023 ( USD Million )
  2. Latin America Serological tests Market By Region, From 2018-2023 ( USD Million )
  3. Latin America Lymphocytic transformation test Market By Region, From 2018-2023 ( USD Million )
  4. Latin America Immunofluorescence staining Market By Region, From 2018-2023 ( USD Million )
  5. Latin America PCR Analysis  Market By Region, From 2018-2023 ( USD Million )
  6. Latin America Urine antigen tests Market By Region, From 2018-2023 ( USD Million )
  7. Latin America Dark field microscopy Market By Region, From 2018-2023 ( USD Million )
  8. Latin America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2018-2023 ( USD Million )
  9. Latin America Molecular diagnostics Market By Region, From 2018-2023 ( USD Million )
  10. Latin America Brain MRI Market By Region, From 2018-2023 ( USD Million )
  11. Latin America Spinal tap Market By Region, From 2018-2023 ( USD Million )
  12. Latin America Echocardiogram Market By Region, From 2018-2023 ( USD Million )
  13. Latin America Electrocardiogram Market By Region, From 2018-2023 ( USD Million )
  14. Latin America Monoclonal antibodies Market By Region, From 2018-2023 ( USD Million )
  15. Latin America Flow cytometry Market By Region, From 2018-2023 ( USD Million )
  16. Latin America Gel micro droplets Market By Region, From 2018-2023 ( USD Million )
  17. Latin America Lyme Disease Diagnostic  Market By End Users, From 2018-2023 ( USD Million )
  18. Latin America Hospitals / Clinics Market By Region, From 2018-2023 ( USD Million )
  19. Latin America Pharmaceutical Industries Market By Region, From 2018-2023 ( USD Million )
  20. Latin America Pathology labs Market By Region, From 2018-2023 ( USD Million )
  21. Latin America Research Institutes Market By Region, From 2018-2023 ( USD Million )
  22. Brazil Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2018-2023 ( USD Million )
  23. Brazil Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2018-2023 ( USD Million )
  24. Brazil Lyme Disease Diagnostic  Market By End Users, From 2018-2023 ( USD Million )
  25. Argentina Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2018-2023 ( USD Million )
  26. Argentina Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2018-2023 ( USD Million )
  27. Argentina Lyme Disease Diagnostic  Market By End Users, From 2018-2023 ( USD Million )
  28. Mexico Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2018-2023 ( USD Million )
  29. Mexico Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2018-2023 ( USD Million )
  30. Mexico Lyme Disease Diagnostic  Market By End Users, From 2018-2023 ( USD Million )
  31. Rest of Latin America Lyme Disease Diagnostic  Market By Diagnostic Tests, From 2018-2023 ( USD Million )
  32. Rest of Latin America Lyme Disease Diagnostic  Market By Diagnostic Technologies, From 2018-2023 ( USD Million )
  33. Rest of Latin America Lyme Disease Diagnostic  Market By End Users, From 2018-2023 ( USD Million )
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-202...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.